Filing Flows › 8-K events › Clorox
Clorox: departure or appointment of directors and officers
Form 8-K filed Oct 29, 2026 · items 5.02, 7.01
CEO changesClorox Appoints Fabian Garcia as CEO
What the filing says
On October 28, 2026, the Board of Directors (the “Board”) of The Clorox Company (the “Company”), appointed Fabian Garcia to serve as the Chief Executive Officer (“CEO”) of the Company and a member of the Board, effective as of January 5, 2027 (the “Effective Date”). Linda Rendle will step down from her role as CEO of t
Read the filing on SEC EDGAR →
What usually followsAcross 39,174 8-Ks reporting Item 5.02 (directors and officers: departures, appointments, pay) in our universe, the stock's median move the next session was −0.1% (typical size ±1.4%, up 48% of the time); over the following 21 sessions, +0.7%. Every item ranked →
What this kind of filing means
Item 5.02 — Departure or appointment of directors and officers. Leadership changes: who leaves, who arrives and on what terms. A sudden CEO or CFO departure without a successor deserves attention.
Clorox at a glance
Clorox, Q1 FY27: revenue $1.9B (+33% year over year), operating margin 10.9%. The chart follows the revenue to costs, profit and cash.
Clorox: every quarter, Q/Q and Y/Y, holders and guidance →
Other recent ceo changes
- CapForce Nov 6, 2026
- Federal Home Loan Bank of New York Nov 6, 2026
- Tri-State Generation & Transmission Association Nov 6, 2026
- GeoVax Labs Nov 6, 2026
- RPM International Nov 6, 2026
- Fox Nov 6, 2026
- Enbridge Nov 6, 2026
- Federal Home Loan Bank of Des Moines Nov 5, 2026
- 1stdibs.com Nov 5, 2026
- TheRealReal Nov 5, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.